Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shirley Chang

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Cancer Biology & Therapy|February 9, 2012
Bortezomib induces apoptosis and growth suppression in human medulloblastoma cells, associated with inhibition of AKT and NF-ĸB signaling, and synergizes with an ERK inhibitorFan Yang, Veronica Jove, Shirley Chang, et al.
Medicine|September 17, 2015
Association of Extrarenal Adverse Effects of Posttransplant Immunosuppression With Sex and ABCB1 HaplotypesRocco C Venuto, Calvin J Meaney, Shirley Chang, et al.
Frontiers in Immunology|March 2, 2026
Risk stratification by donor-derived cell-free DNA: a three-year single center study of kidney transplant outcomes from 257 patientsRhys Mendel, Kabir Jalal, Lin Liu, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Cancer Biology & Therapy|February 9, 2012
Bortezomib induces apoptosis and growth suppression in human medulloblastoma cells, associated with inhibition of AKT and NF-ĸB signaling, and synergizes with an ERK inhibitorFan Yang, Veronica Jove, Shirley Chang, et al.
Medicine|September 17, 2015
Association of Extrarenal Adverse Effects of Posttransplant Immunosuppression With Sex and ABCB1 HaplotypesRocco C Venuto, Calvin J Meaney, Shirley Chang, et al.
Frontiers in Immunology|March 2, 2026
Risk stratification by donor-derived cell-free DNA: a three-year single center study of kidney transplant outcomes from 257 patientsRhys Mendel, Kabir Jalal, Lin Liu, et al.
Pageof 2